Literature DB >> 11792661

Expression and binding activity of the glucocorticoid receptor are upregulated in septic muscle.

Xiaoyan Sun1, David R Fischer, Timothy A Pritts, Curtis J Wray, Per-Olof Hasselgren.   

Abstract

We examined the influence of sepsis, induced by cecal ligation and puncture in rats, on the protein and gene expression and hormone binding activity of the glucocorticoid receptor (GR) in skeletal muscle. Sepsis resulted in increased GR mRNA and protein levels and upregulated hormone binding activity in extensor digitorum longus and soleus muscles. Scatchard analysis suggested that the increased GR hormone binding activity reflected an increased number of hormone binding sites, whereas receptor affinity for glucocorticoids was unchanged. The GR antagonist RU-38486 blocked the sepsis-induced increase in GR expression and hormone binding activity, implicating a positive regulatory effect of glucocorticoids on GR expression and binding activity under the present experimental conditions. The results suggest that glucocorticoid-dependent metabolic changes in skeletal muscle during sepsis may reflect not only high circulating glucocorticoid levels but increased amounts and hormone binding activity of the GR as well.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792661     DOI: 10.1152/ajpregu.00509.2001

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  14 in total

1.  Glucocorticoid Cell Priming Enhances Transfection Outcomes in Adult Human Mesenchymal Stem Cells.

Authors:  Abby M Kelly; Sarah A Plautz; Janos Zempleni; Angela K Pannier
Journal:  Mol Ther       Date:  2015-10-19       Impact factor: 11.454

2.  FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy.

Authors:  Bin Zheng; Sakae Ohkawa; Haiyan Li; Tiffany K Roberts-Wilson; S Russ Price
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

3.  Characterization of the Glucocorticoid Receptor in Children Undergoing Cardiac Surgery.

Authors:  Saul Flores; David S Cooper; Amy M Opoka; Ilias Iliopoulos; Sarah Pluckebaum; Matthew N Alder; Kelli A Krallman; Rashmi D Sahay; Lin Fei; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2018-08       Impact factor: 3.624

4.  Glucocorticoids and TNFalpha interact cooperatively to mediate sepsis-induced leucine resistance in skeletal muscle.

Authors:  Charles H Lang; Robert A Frost
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

5.  The hepatoadrenal syndrome: a common yet unrecognized clinical condition.

Authors:  Paul E Marik; Timothy Gayowski; Thomas E Starzl
Journal:  Crit Care Med       Date:  2005-06       Impact factor: 7.598

6.  TNF-alpha and glucocorticoid receptor interaction in L6 muscle cells: a cooperative downregulation of myosin heavy chain.

Authors:  Bassem H Dekelbab; Selma F Witchel; Donald B DeFranco
Journal:  Steroids       Date:  2007-06-02       Impact factor: 2.668

Review 7.  Muscle plasticity and β₂-adrenergic receptors: adaptive responses of β₂-adrenergic receptor expression to muscle hypertrophy and atrophy.

Authors:  Shogo Sato; Ken Shirato; Kaoru Tachiyashiki; Kazuhiko Imaizumi
Journal:  J Biomed Biotechnol       Date:  2011-11-15

8.  Impact of glucocorticoid receptor density on ligand-independent dimerization, cooperative ligand-binding and basal priming of transactivation: a cell culture model.

Authors:  Steven Robertson; Johann M Rohwer; Janet P Hapgood; Ann Louw
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

9.  PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting.

Authors:  Estibaliz Castillero; Nima Alamdari; Zaira Aversa; Aniket Gurav; Per-Olof Hasselgren
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.752

10.  Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsis.

Authors:  Erica L T van den Akker; Jan W Koper; Koen Joosten; Frank H de Jong; Jan A Hazelzet; Steven W J Lamberts; Anita C S Hokken-Koelega
Journal:  Intensive Care Med       Date:  2009-04-17       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.